Replies to post #110401 on Biotech Values

[DewDiligence]

CRXL buyout: It’s amusing that the author of this graphic from
two years ago considered CRXL a target of buyout interest from
NVS, GSK, SNY, and MRK—i.e. just about everyone except JNJ.

[DewDiligence]

JNJ-CRXL deal is all systems go:

http://finance.yahoo.com/news/Minimum-Acceptance-Condition-prnews-2757052081.html?x=0&.v=1